Pomalidomide 4'-PEG5-acid

CAS : 2139348-63-1

Ref. 3D-PKD34863

Informations sur le produit

• Nom: Pomalidomide 4'-PEG5-acid

Description

Pomalidomide 4'-PEG5-acid is a product that combines the benefits of pomalidomide and PEGylation. Pomalidomide is a medication used to treat multiple myeloma, while PEGylation involves attaching polyethylene glycol (PEG) to a drug molecule. This combination offers several advantages, including increased solubility, improved stability, and reduced immunogenicity.

The amido PEG linker in Pomalidomide 4'-PEG5-acid ensures a stable attachment between pomalidomide and PEG. This linkage allows for controlled release of the drug in the body, leading to sustained therapeutic effects.

PEG products have been widely used in pharmaceuticals due to their biocompatibility and ability to enhance drug delivery. The acid PEG variant used in this product further enhances its stability and bioavailability.

Overall, Pomalidomide 4'-PEG5-acid is a cutting-edge solution that combines the therapeutic benefits

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 565.6 g/mol
• Formule: C₂₆H₃₅N₃O₁₁
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder